Sage Therapeutics
SAGE
#7026
Rank
S$0.70 B
Marketcap
S$11.21
Share price
0.00%
Change (1 day)
3.92%
Change (1 year)

Operating Margin for Sage Therapeutics (SAGE)

Operating Margin as of December 2025 (TTM): -427.77%

According to Sage Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -427.77%. At the end of 2024 the company had an Operating Margin of -971.48%.

Operating Margin history for Sage Therapeutics from 2019 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-971.48%55.11%
2023-626.32%-90.96%
2022-6,931.88%-4.51%
2021-7,258.91%-13444.72%
202054.40%-100.55%
2019-9,904.46%2297.82%
2018-413.06%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Regulus Therapeutics
RGLS
-118.00%-72.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
13.84%-103.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
14.06%-103.29%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
-59.02%-86.20%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.